articleGastroenterologyNov 5, 2011Closed access

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

WJWilliam J. SandbornGVGert Van AsscheWRWalter ReinischJCJean‐Frédéric ColombelGDGeert D’Haens

University of California, San Diego · Universitair Ziekenhuis Leuven · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,253
total citations
FWCI
44.16
Percentile
100%
References
16
Citations per year

Authors

10

Topics & keywords

Topics
Keywords
  • Ulcerative colitis
  • Adalimumab
  • Medicine
  • Gastroenterology
  • Internal medicine
  • Vedolizumab
  • Tumor necrosis factor alpha
  • Disease
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding